Lind Global Fund II LP 13D and 13G filings for NLS Pharmaceutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-27 7:37 pm Purchase | 2024-03-22 | 13G | NLS Pharmaceutics AG NLSP | Lind Global Fund II LP | 10,750 9.900% | 10,750 (New Position) | Filing |